Cheapest GLP-1 Injections 2026: Most Affordable Semaglutide & Tirzepatide
Compare the cheapest GLP-1 injections in 2026. Ranked pricing for compounded semaglutide and tirzepatide from Trimi, Hims, Ro, Found, Henry Meds, Calibrate, and Sequence.
Written by Trimi Medical Team
Medically reviewed by Dr. Amanda Foster, MD
More on GLP-1 Cost & Access
Hims Promo Code 2026
Current discounts and coupon codes for Hims weight loss.
Ro Promo Code 2026
Active promo codes for Ro weight loss program.
Found Promo Code 2026
Latest discounts for Found weight loss membership.
Best Compounded GLP-1 Providers
Ranked comparison of all compounded GLP-1 telehealth platforms.
What Are the Cheapest GLP-1 Injections in 2026?
The cheapest GLP-1 injections available in 2026 are compounded semaglutide and compounded tirzepatide dispensed through telehealth providers that partner with FDA-registered 503B outsourcing pharmacies. These compounded formulations contain the same active pharmaceutical ingredients as brand-name Wegovy (semaglutide) and Zepbound (tirzepatide) but cost 70-90% less because they bypass the brand-name markup, patent-protected pricing, and massive marketing overhead charged by Novo Nordisk and Eli Lilly.
In practical terms, the most affordable compounded semaglutide starts at $99/month through providers like Trimi, compared to $1,100-$1,350/month for brand-name Wegovy without insurance. Compounded tirzepatide starts at $125/month versus $1,000-$1,300/month for brand-name Zepbound. The cost difference over a 12-month treatment course can exceed $12,000.
What Are Compounded GLP-1s?
Compounded GLP-1 medications are produced by FDA-registered 503B outsourcing facilities -- large-scale compounding pharmacies that operate under direct FDA oversight. Unlike traditional 503A pharmacies that fill individual prescriptions, 503B facilities manufacture medications in bulk under current Good Manufacturing Practice (cGMP) standards, with mandatory potency testing, sterility testing, and regular FDA inspections.
These pharmacies are legally permitted to compound medications when the brand-name version faces documented shortages or when a specific patient need exists. Because they produce the active ingredient without the pharmaceutical company's R&D recoupment, marketing budget, or patent premium, the resulting medication costs a fraction of the brand-name price.
The GLP-1 medication class -- which includes semaglutide, tirzepatide, and liraglutide -- has produced some of the most significant weight loss outcomes ever documented in clinical trials. Semaglutide demonstrated 14.9% average body weight reduction in the STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021), while tirzepatide achieved 22.5% in SURMOUNT-1 (Jastreboff et al., New England Journal of Medicine, 2022). These results were previously achievable only through bariatric surgery. The access barrier has always been cost -- and in 2026, compounded options have made that barrier substantially lower.
2026 GLP-1 Provider Price Comparison: Full Rankings
The following table compares every major telehealth provider offering compounded GLP-1 injections in 2026, ranked by lowest semaglutide price. All prices reflect publicly available cash-pay rates as of April 2026. We include consultation fees, contract requirements, and projected 12-month totals to give you the true all-in cost.
| Provider | Semaglutide/mo | Tirzepatide/mo | Consultation | Contract | 12-Month Total |
|---|---|---|---|---|---|
| TrimiLowest price | $99 | $125 | Free | None | $1,188 |
| Ro | $99-$199 | $199-$349 | Included | Monthly | $1,188-$2,388 |
| Found | $129-$199 | $199-$299 | Included | Monthly | $1,548-$2,388 |
| Hims/Hers | $149-$199 | $199-$299 | Included | Monthly | $1,788-$2,388 |
| Henry Meds | $199-$349 | $299-$449 | $49-$99 | Monthly | $2,388-$4,188+ |
| Calibrate | Program $1,649/yr + meds | N/A | Included | 1-year | $1,649-$3,000+ |
| Sequence | $249-$399 | $349-$399 | Included | Some plans | $2,988-$4,788 |
Prices reflect publicly listed cash-pay rates as of April 2026 and are subject to change. The 12-month total is calculated using the lowest available monthly medication price plus any stated consultation fees. Confirm current pricing directly with each provider before enrolling.
Key Takeaway
Trimi offers the lowest flat-rate pricing for both semaglutide ($99/mo) and tirzepatide ($125/mo) with no consultation fee and no contract. Over 12 months of semaglutide treatment, you would pay $1,188 with Trimi compared to $1,788-$4,788+ with other providers -- a savings of $600 to $3,600 per year.
Breaking Down the Cost Differences
The price variation across providers comes down to several factors. Some providers like Ro and Found price their lower doses competitively but charge significantly more as patients titrate to higher, maintenance-level doses. This means the $99 or $129 starting price may climb to $199+ within a few months. Trimi maintains the same flat rate regardless of dose, which is a meaningful difference over a full treatment course.
Hidden costs also play a role. Henry Meds charges a separate consultation fee of $49-$99 on top of medication pricing. Calibrate operates a year-long program model with an upfront commitment of $1,649 that covers coaching and metabolic testing, but the medication cost is additional. For an in-depth review of Calibrate's pricing structure, see our Calibrate cost breakdown. Sequence's higher base pricing reflects their emphasis on multi-omics testing and a more intensive clinical model.
Contract requirements matter as well. Providers with month-to-month billing like Trimi allow you to pause or cancel without penalty. Some Calibrate plans require a 12-month commitment, and certain Sequence plans include minimum enrollment periods. If you are unsure how long you will need treatment or want to test a provider before committing, month-to-month flexibility is essential. For a side-by-side comparison of these program structures, see our best compounded GLP-1 providers guide.
Why Compounded GLP-1s Are Cheaper Than Brand-Name
The price difference between brand-name and compounded GLP-1 medications is dramatic -- and understanding why is important for making an informed decision. Brand-name Wegovy carries a list price of approximately $1,100-$1,350 per month. Brand-name Zepbound (tirzepatide for obesity) runs $1,000-$1,300 monthly. Even with manufacturer savings cards, many patients pay $300-$500/month out of pocket after insurance.
Compounded versions of these same molecules cost $99-$450/month depending on the provider and medication. That 70-90% cost reduction exists because 503B compounding pharmacies operate a fundamentally different business model than pharmaceutical manufacturers like Novo Nordisk and Eli Lilly. Here is what accounts for the price gap:
No R&D recoupment
Novo Nordisk spent billions developing semaglutide through Phase 1-3 clinical trials, FDA approval processes, and post-market surveillance studies. Brand-name pricing recovers this investment. Compounding pharmacies produce an established molecule without these costs.
No patent premium
Brand-name medications carry patent-protected pricing that limits competition. Compounding under 503B regulations operates in a separate legal pathway that allows production when shortage or clinical need conditions are met.
No direct-to-consumer marketing
Pharmaceutical companies spend hundreds of millions annually on TV advertising, physician outreach, and promotional campaigns. Compounding pharmacies do not market to consumers and carry none of this overhead.
Streamlined manufacturing
503B outsourcing facilities focus on efficient, high-volume production of specific formulations under cGMP standards. This specialization reduces per-unit production costs compared to the diverse manufacturing pipelines of major pharma companies.
It is important to note that 503B outsourcing facilities are not the same as small, independent compounding pharmacies that fill individual prescriptions. 503B facilities are registered with the FDA, subject to regular FDA inspections, and required to follow current Good Manufacturing Practice standards. They test every batch for potency, sterility, and endotoxin levels. This regulatory framework exists specifically to ensure quality and safety at scale.
For a deeper look at how compounded semaglutide compares to brand-name Wegovy in terms of clinical performance, see our compounded vs brand-name semaglutide comparison.
What to Look For in an Affordable GLP-1 Provider
Not all low-cost GLP-1 providers are equal. Price should not be the only factor when choosing where to get your medication. The following checklist covers the essential criteria that separate reputable affordable providers from those cutting corners on quality or safety.
Provider Quality Checklist
503B-registered pharmacy partner
Ensures FDA oversight, cGMP compliance, batch testing for potency and sterility, and regular inspections. This is the single most important quality indicator.
Licensed prescribers in your state
Your prescribing provider must hold an active medical license in the state where you reside. Legitimate platforms verify this and will not prescribe across unlicensed state lines.
No hidden fees or upsells
The quoted medication price should be your total cost. Watch for separate consultation fees, enrollment fees, shipping charges, or mandatory add-on supplements.
Month-to-month billing with no contracts
You should be able to pause or cancel your subscription at any time without financial penalty. Long-term contracts lock you in even if the medication does not work for you.
Transparent dosing and titration protocol
A reputable provider follows standard titration schedules (starting low, increasing gradually) and will not jump you to high doses prematurely. Your provider should communicate the titration plan clearly.
Responsive medical support
You should have a clear channel to contact your prescribing provider with questions about side effects, dosing concerns, or treatment adjustments. Response times within 24-48 hours are the standard.
Flat-rate pricing across dose levels
Some providers charge more as your dose increases. Flat-rate pricing means your cost stays the same whether you are on 0.25mg or 2.4mg semaglutide, protecting you from surprise price increases during treatment.
Red Flags to Avoid
- Prices significantly below $80/month -- may indicate lower-quality compounding sources, diluted formulations, or non-503B pharmacies without proper quality controls.
- No medical consultation required -- GLP-1 medications are prescription drugs that require a licensed provider to evaluate your medical history, contraindications, and eligibility.
- Refuses to name pharmacy partner -- any legitimate provider should openly disclose the 503B pharmacy that compounds their medication.
- Guaranteed specific weight loss results -- individual results vary based on adherence, diet, exercise, and metabolic factors. No provider can guarantee a specific outcome.
- No follow-up or monitoring -- proper GLP-1 treatment requires ongoing provider oversight for dose adjustments, side effect management, and progress evaluation.
Trimi meets every criterion on this checklist: 503B pharmacy partners, licensed providers in all operating states, flat-rate pricing ($99 semaglutide, $125 tirzepatide), no consultation fee, no contract, and responsive medical support included in the price. For detailed reviews of other providers, see our best online weight loss provider 2026 comparison.
Brand-Name vs Compounded: Clinical Equivalence
One of the most common concerns about cheaper GLP-1 injections is whether they work as well as the brand-name versions. The clinical evidence is clear: compounded semaglutide and compounded tirzepatide contain the same active pharmaceutical ingredient as their brand-name counterparts and activate the same biological pathways.
The landmark clinical trials that established the efficacy of these medications tested the molecule itself -- not the brand packaging. When Wilding et al. published the STEP 1 results in the New England Journal of Medicine (2021), demonstrating that semaglutide 2.4mg produced 14.9% average body weight loss over 68 weeks with 86.4% of participants losing at least 5% of body weight, those outcomes were driven by the semaglutide molecule. The same molecule is what compounding pharmacies produce.
Similarly, when Jastreboff et al. published the SURMOUNT-1 trial results in the New England Journal of Medicine (2022), showing that tirzepatide 15mg produced 22.5% average weight loss over 72 weeks with 56.7% of participants achieving at least 20% body weight reduction, those results were attributable to the tirzepatide molecule. The compounded version delivers the same active compound.
Key Clinical Trial Outcomes
| Trial | Medication | Avg. Weight Loss | Duration | Citation |
|---|---|---|---|---|
| STEP 1 | Semaglutide 2.4mg | 14.9% | 68 weeks | Wilding et al., NEJM 2021 |
| SURMOUNT-1 | Tirzepatide 15mg | 22.5% | 72 weeks | Jastreboff et al., NEJM 2022 |
| SELECT | Semaglutide 2.4mg | 9.4% + CV benefit | 40 months | Lincoff et al., NEJM 2023 |
| SURMOUNT-2 | Tirzepatide 15mg (T2D) | 14.7% | 72 weeks | Garvey et al., Lancet 2023 |
The SELECT trial (Lincoff et al., New England Journal of Medicine, 2023) added an important dimension: semaglutide 2.4mg reduced major adverse cardiovascular events by 20% in patients with pre-existing cardiovascular disease over a median follow-up of 40 months. This cardiovascular benefit applies to the semaglutide molecule regardless of whether it comes in branded Wegovy packaging or a compounded vial.
The practical implication is straightforward: if you cannot afford brand-name Wegovy at $1,100+/month, compounded semaglutide from a licensed 503B pharmacy delivers the same active ingredient at $99-$200/month. The clinical evidence backing that molecule is identical. For patients considering tirzepatide, the same logic applies -- compounded tirzepatide at $125-$450/month versus brand-name Zepbound at $1,000+/month uses the same pharmacologically active compound. Read our tirzepatide vs semaglutide comparison to determine which molecule may be the better fit for your goals.
Provider-by-Provider Cost Breakdown
Trimi -- $99/month Semaglutide, $125/month Tirzepatide
Trimi is a purpose-built weight loss platform that offers the most consistently affordable GLP-1 pricing in 2026. The flat-rate model means your cost stays at $99/month for semaglutide or $125/month for tirzepatide regardless of your dose level. There are no consultation fees, no enrollment fees, and no required contracts. Medication ships from 503B-registered compounding pharmacies, and ongoing medical support is included in the price. Over 12 months of semaglutide treatment, the total cost is $1,188 -- the lowest all-in cost of any major provider.
Hims/Hers -- $149-$199/month Semaglutide
Hims is one of the largest telehealth platforms in the U.S. and offers compounded semaglutide starting at $149/month and tirzepatide from $199/month. Consultations are included in the price. As the largest general telehealth platform, Hims benefits from brand recognition but treats weight loss as one of many product categories alongside skincare, hair loss, and sexual health. Pricing is competitive at the entry level but costs increase with higher doses. The 12-month range of $1,788-$2,388 for semaglutide reflects this dose-dependent pricing. Check our Hims promo code page for any current discounts.
Ro -- $99-$199/month Semaglutide
Ro (formerly Roman) offers a competitive starting price for compounded semaglutide that matches Trimi at the lowest dose tier. However, pricing scales up to $199/month at higher doses, and tirzepatide ranges from $199-$349/month. Consultation is included. Ro is an established telehealth platform with a solid medical team, though weight loss is one of several service lines. The effective 12-month range of $1,188-$2,388 reflects the dose-dependent pricing model. For potential savings, see our Ro promo code guide.
Found -- $129-$199/month Semaglutide
Found is a weight-loss-focused platform offering compounded semaglutide from $129/month and tirzepatide from $199/month, with consultations included. Found's approach includes behavioral health components and may prescribe non-GLP-1 medications (metformin, bupropion/naltrexone) if their providers determine a different medication is more appropriate. The 12-month cost range of $1,548-$2,388 places them in the mid-range of providers. See our Found promo code page for active discounts.
Henry Meds -- $199-$349/month Semaglutide
Henry Meds prices compounded semaglutide at $199-$349/month and tirzepatide at $299-$449/month. A separate consultation fee of $49-$99 adds to the initial cost. This makes Henry Meds one of the more expensive compounded GLP-1 options in 2026, with 12-month totals reaching $2,388-$4,188+. The platform does offer a more concierge-style experience with personalized provider attention.
Calibrate -- $1,649/year Program + Medication
Calibrate operates a different model: a year-long metabolic health program priced at $1,649 that includes coaching, metabolic testing, and a curriculum alongside GLP-1 medication. The medication cost is additional, pushing total 12-month spending to $1,649-$3,000+ depending on the medication prescribed. Calibrate primarily works with insurance for brand-name medications and does not offer compounded tirzepatide. The 1-year commitment and higher total cost position Calibrate as a premium option rather than a budget choice. For a full breakdown, read our Calibrate review.
Sequence -- $249-$399/month Semaglutide
Sequence is the highest-priced major provider for compounded GLP-1 injections, with semaglutide at $249-$399/month and tirzepatide at $349-$399/month. The higher price reflects their emphasis on advanced diagnostics, multi-omics testing, and a data-intensive clinical approach. Consultations are included, and some plans have minimum enrollment periods. The 12-month total of $2,988-$4,788 makes Sequence the most expensive option on this list. Patients who value detailed biomarker tracking may find the premium worthwhile; those prioritizing cost will find better options elsewhere.
The Bottom Line: Who Offers the Cheapest GLP-1 Injections?
After comparing every major provider, Trimi offers the most consistently affordable GLP-1 injections in 2026. At $99/month for semaglutide and $125/month for tirzepatide -- with no consultation fees, no contracts, and flat-rate pricing across all dose levels -- Trimi delivers the lowest all-in cost for patients who prioritize affordability without sacrificing quality of care.
The $1,188 annual cost for semaglutide through Trimi is $600-$3,600 less than what you would pay through other major providers, and roughly $12,000-$15,000 less than brand-name Wegovy without insurance. Every dollar saved on medication is a dollar that can go toward the healthy food, protein supplements, and gym memberships that support long-term weight loss success.
Why Trimi Is the Most Affordable Choice
For patients ready to start treatment, Trimi's online consultation takes minutes to complete and there is no upfront cost. A licensed provider reviews your medical history, and if appropriate, your medication ships directly to your door from a 503B pharmacy.
Frequently Asked Questions
What is the cheapest GLP-1 injection available in 2026?
Compounded semaglutide through Trimi is currently the cheapest GLP-1 injection at $99/month with no consultation fees and no long-term contracts. This price includes licensed provider oversight, medication from a 503B-registered compounding pharmacy, and free shipping.
Is compounded semaglutide as effective as brand-name Wegovy?
Compounded semaglutide contains the same active pharmaceutical ingredient as Wegovy and works through identical GLP-1 receptor agonism. When sourced from a licensed 503B compounding pharmacy with proper quality testing, it produces comparable clinical outcomes. The STEP 1 trial data for semaglutide applies to the same molecule used in compounded formulations.
Why is compounded semaglutide so much cheaper than Wegovy?
Brand-name Wegovy costs $1,100-$1,350/month because its price includes Novo Nordisk's research and development investment, FDA approval costs, marketing, and patent-protected pricing. Compounded semaglutide is produced by 503B-registered pharmacies that manufacture the same active ingredient without these overhead costs, passing savings directly to patients.
Do I need insurance to get affordable GLP-1 injections?
No. Compounded GLP-1 injections through telehealth providers like Trimi do not require insurance. The cash-pay pricing of $99-$125/month is often cheaper than insured copays for brand-name medications. This makes compounded options the most accessible path for uninsured or underinsured patients.
Are there hidden fees with cheap GLP-1 providers?
Some providers advertise low medication prices but add consultation fees ($49-$99), enrollment fees, or require multi-month commitments. Trimi includes the provider consultation in the medication price with no hidden fees and no contracts. Always verify total cost including all fees before starting treatment.
How do I know if a compounding pharmacy is legitimate?
Look for 503B-registered outsourcing facilities that operate under FDA oversight. Reputable providers will disclose their pharmacy partners and can confirm 503B registration, third-party potency testing, sterility testing, and cGMP compliance. Avoid any provider that cannot identify their pharmacy source.
Can I switch from an expensive GLP-1 provider to a cheaper one?
Yes. If you are already on semaglutide or tirzepatide through a higher-cost provider, you can switch to a more affordable option like Trimi. Your new provider will review your medical history and current dosing to ensure a smooth transition without interrupting treatment.
Sources & References
- Wilding JPH, Batterham RL, Calanna S, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine. 2021;384(11):989-1002. (STEP 1 Trial)
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." New England Journal of Medicine. 2022;387(3):205-216. (SURMOUNT-1 Trial)
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. "Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes." New England Journal of Medicine. 2023;389(24):2221-2232. (SELECT Trial)
- Garvey WT, Frias JP, Jastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity in People with Type 2 Diabetes." The Lancet. 2023;402(10402):613-626. (SURMOUNT-2 Trial)
- U.S. Food and Drug Administration. "Compounding and the FDA: Questions and Answers." FDA Guidance Document, updated 2024.
- U.S. Food and Drug Administration. Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide). FDA.gov.